Free Pharmacist mock test
25 original exam-style questions from our Pharmacist bank, timed at the exam’s own pace, scored against the 60% DHA pass mark. They span 13 of the 13 blueprint domains, so you will see exactly where you are weakest - free, no sign-up.
Sit 25 original exam-style questions at real exam pace
These are 25 original questions taken from our Pharmacist bank, spread across 13 of the 13 domains of the published blueprint. You get 72 seconds per question, which is exactly the pace of the real PHO5481 exam (30 minutes for 25). At the end you will see which domains you are weakest in, and the full worked reasoning for every question.
- 25
- questions
- 30:00
- time limit
- 60%
- DHA pass mark
A short diagnostic cannot predict whether you will pass - only the real exam does that. It will show you, honestly, where you currently stand.
Quick answer
The Pharmacist exam at a glance
The Pharmacist licensing exam is a computer-based, multiple-choice test, and each GCC regulator sets its own. DHA, DOH, SCFHS, QCHP and OMSB publish exact figures, listed below. This free mock gives you 25 original exam-style questions at 72 seconds each, scored against the 60% DHA pass mark, then shows your weakest domains.
Published exam figures
- DHA
Pharmacist (PHO5481)
UAE150 MCQs3 hours60%
pass mark
- DOH
Pharmacist CBT
UAE50-100 MCQs1-2 hoursPass / fail only
pass mark
- SCFHS
Saudi Pharmacist Licensure Examination (SPLE)
Saudi Arabia200 MCQs240 minutes536 on a 200-800 scale
pass mark
- QCHP
Pharmacist
Qatar150 MCQs3 hours60%
pass mark
- OMSB
Omani Examination for Pharmacists (OEP)
Oman100 MCQs150 minutes60%
pass mark
- Attempts in the UAE
- 3 in total across DHA, DOH, MOHAP and SHA
- This free mock
- 25 questions · 30 minutes · 13 of 13 domains
- Full bank
- 405+ questions · 3 to 6 papers · AED 269
- Regulators
- DHA, DOH, SCFHS, QCHP, OMSB, MOHAP, SHA, NHRA and Kuwait MOH
How this free Pharmacist mock works
- 25
- original questions
- 30 min
- time limit
- 72s
- per question
- 13 of 13
- blueprint domains
- You get 72 seconds per question, the pace of a 150-question paper in 3 hours. The timer runs in your browser and ends the sitting when it reaches zero.
- Your score is set against the 60% DHA pass mark, the published figure for this exam. No other number is invented: there is no percentile and no pass probability.
- At the end you see your score, your pace per question, every domain ranked weakest first, and the worked answer and source for all 25 questions.
- You can mark each answer “sure” or “not sure”. Wrong answers you were sure about are shown first, because they are the ones you would not stop to check in the real exam.
- Your last result is saved in your own browser only, so you can come back and compare. Nothing is sent to us.
What the real Pharmacist licensing exam looks like
The Pharmacist exam is a computer-based multiple-choice paper, published by 5 regulators: DHA PHO5481 (pass mark 60%), DOH (pass mark Pass / fail only), SCFHS SPLE (pass mark 536/800), QCHP (pass mark 60%), OMSB OEP (pass mark 60%). Every regulator's format, pass mark and fee is in the table below; confirm yours before booking.
Pass marks at a glance: exam codes and pass marks by regulator for every written exam in one sourced table.
Before you can book the exam at all you need Dataflow primary source verification of your degree, licence and experience, which typically runs several weeks. Candidates often underestimate this and end up sitting the exam sooner after study than they planned. Check where you stand with our free eligibility checker or confirm whether your title even requires an exam using the Prometric exam checker.
You get three attempts in total across all UAE authorities, not three each, under the Unified Professional Qualification Requirements. At roughly AED 880 per attempt, plus the licensing delay each failure adds to your visa and start date, the cost of going in underprepared is not really the exam fee.
| Regulator | Exam | Format | Pass mark | Fee per attempt |
|---|---|---|---|---|
Pharmacist (PHO5481) | 150 MCQs in 3 hours | 60% | USD 240 (about AED 880) | |
Pharmacist CBT | 50-100 MCQs in 1-2 hours | Pass / fail only | AED 550 | |
| 200 MCQs in 240 minutes | 536 on a 200-800 scale | Not published | ||
Pharmacist | 150 MCQs in 3 hours | 60% | Not published | |
Omani Examination for Pharmacists (OEP) | 100 MCQs in 150 minutes | 60% | USD 200 (about OMR 80) | |
MOHAP licensing exam Regulator-wide format | Computer-based | Not published | Not published | |
SHA licensing exam Regulator-wide format | Set at assessment | Not published | Not published | |
NHRA licensing exam Regulator-wide format | Prometric CBT | Not published | Not published | |
No exam published for this title Kuwait MOH publishes no exam for this title; check with the MOH | Not published | Not published | Not published |
Highlighted rows publish figures for this exact Pharmacist exam; the others show the regulator's general rules.
What is on the Pharmacist exam: the full blueprint
The published blueprint splits into 13 domains and 183 testable sub-topics. For each one you can see its weight, how many questions this mock asks on it, and about how many the full bank holds.
- Clinical Therapeutics & Disease-State Management~30%
22 sub-topics · 4 in this mock · about 148 in the full bank
DHA lists 'Pharmaceutical Care & Disease State Management' at 35%; SCFHS Clinical Sciences 35%
- Pharmacology, Drug Classes, ADRs & Drug Interactions~12%
15 sub-topics · 1 in this mock · about 59 in the full bank
est.; core of SCFHS Pharmaceutical Sciences 35%
- Pharmaceutical Calculations & Compounding~12%
15 sub-topics · 1 in this mock · about 59 in the full bank
DHA 'Pharmacy Calculation & Compounding' 15%; SCFHS Sterile/Nonsterile Compounding
- Pharmaceutics, Biopharmaceutics & Pharmacokinetics~8%
15 sub-topics · 1 in this mock · about 40 in the full bank
est.; SCFHS Pharmaceutics 2.4 & Pharmacokinetics 2.5
- Medicinal Chemistry, Pharmacognosy & Dietary Supplements~6%
11 sub-topics · 3 in this mock · about 30 in the full bank
est.; SCFHS Medicinal Chemistry 2.1 & Pharmacognosy 2.3
- Basic Biomedical Sciences~6%
13 sub-topics · 4 in this mock · about 30 in the full bank
SCFHS Basic Biomedical Sciences 10%
- Nonprescription (OTC) & Self-Care / Counter Medication~6%
12 sub-topics · 3 in this mock · about 30 in the full bank
DHA 'Counter Medication' 10%
- Special Populations~5%
12 sub-topics · 1 in this mock · about 25 in the full bank
DHA lists Pregnancy/Lactation 5%, Pediatrics 5%, Geriatrics 5%
- Toxicology & Poisoning Management~5%
12 sub-topics · 1 in this mock · about 25 in the full bank
DHA Toxicology 5%; SCFHS acute/chronic toxicity
- Patient Assessment, Counseling, Drug Information & Evidence-Based Practice~5%
14 sub-topics · 3 in this mock · about 25 in the full bank
est.; SCFHS Clinical 4.1, 4.5 & Professional Communication 3.8
- Pharmacy Law, Ethics & Regulatory Affairs~6%
14 sub-topics · 1 in this mock · about 30 in the full bank
DHA Law & Ethics 10%; SCFHS 3.5 & 3.7
- Public Health, Pharmacoeconomics, Pharmacoepidemiology & Biostatistics~5%
14 sub-topics · 1 in this mock · about 25 in the full bank
est.; SCFHS Social/Behavioral/Administrative 3.1-3.3, 3.6
- Pharmacy Practice Management, Medication Safety & Dispensing Systems~5%
14 sub-topics · 1 in this mock · about 25 in the full bank
DHA Medication Safety 5%; SCFHS 3.4 & 3.10
Bank counts are estimates from the published weights the bank is written to, rounded.
This mock samples 13 of 13 domains. The full bank covers all 13 across 405+ questions.
See the full bank - AED 269How to use your mock score
These bands are set against the 60% DHA pass mark and match the verdict on your result screen. On 25 questions, a score near the pass mark has a 95% margin of error of about ±19 points, so treat the band as a direction, not a forecast.
Below the line
On this sample you would likely fall short of the 60% pass mark today. Do not book yet. Start with your two weakest domains from the result, then sit full-length papers until you clear the line with room to spare.
Close to the line
A few questions decide it. On a 135-question paper, every 1% is one or two questions, so drill your weakest domains and build a margin on timed papers before you book.
On track
Clear of the pass mark on this sample. 25 questions is a small sample, so confirm it over full-length timed papers before you book: stamina and pacing fail candidates who know the material.
Getting an honest score
- 1Sit it cold, once. Do not look anything up. A diagnostic you help yourself through tells you nothing. The number you get is only useful if it is honest.
- 2Read every rationale, especially the ones you got right. Getting a question right by elimination is not the same as knowing it. The worked reasoning is free, whether or not you buy anything.
- 3Work on your weakest domain first. The breakdown orders your domains worst first for exactly this reason. Studying what you are already good at feels productive and moves nothing.
- 4Re-sit under full exam conditions later. The real paper is much longer than 25 questions and stamina matters. The full bank's 3 to 6 papers are written for exactly this.
A worked Pharmacist exam question
Every question in the mock and in the paid bank is written to this standard: a clinical stem, four plausible options and the reasoning for the answer, with its source.
Public Health, Pharmacoeconomics, Pharmacoepidemiology & Biostatistics
A pharmacist wants to improve adherence in a patient ambivalent about starting a statin. Which counseling approach is most consistent with evidence-based behavior change and respects patient autonomy?
- AWarning the patient repeatedly about death to induce fear
- BMotivational interviewing to explore the patient's own reasons for changeCorrect
- CRefusing to dispense unless the patient agrees to lifelong therapy
- DProviding a detailed pharmacology lecture on statin mechanism
Why: Motivational interviewing is a collaborative, patient-centered approach that helps resolve ambivalence by eliciting the patient's own motivations, and it improves adherence while respecting autonomy. Fear-based repetition, coercive refusal to dispense, and dense pharmacology lectures are not patient-centered, tend to raise resistance, and are not evidence-based methods for supporting sustained behavior change.
Source: Miller & Rollnick, Motivational Interviewing (foundational); WHO Adherence to Long-Term Therapies (2003)
Pharmacist sample questions with answers
10 more original exam-style Pharmacist questions, worked in full. They are not real or recalled exam questions, and none of them is in the mock above or on the bank page, so sit the mock first if you have not.
Question 1 · Pharmacology, Drug Classes, ADRs & Drug Interactions
A non-diabetic patient with heart failure with reduced ejection fraction is prescribed dapagliflozin. Which statement about this indication is correct?
- AIt is approved only for glycemic control and has no role in heart failure
- BIt is contraindicated in any patient without diabetes
- CIt is approved to reduce cardiovascular death and heart-failure hospitalization in HFrEF, including non-diabetics
- DIt is indicated exclusively for type 1 diabetes
Show answer and explanation
Correct answer: C. It is approved to reduce cardiovascular death and heart-failure hospitalization in HFrEF, including non-diabetics
SGLT2 inhibitors such as dapagliflozin are approved to reduce cardiovascular death and heart-failure hospitalization in patients with HFrEF regardless of diabetes status, based on trials like DAPA-HF. They are not restricted to diabetics, are not contraindicated in non-diabetics, and are not indicated for type 1 diabetes management.
Reference: 2022 AHA/ACC/HFSA Heart Failure Guideline; DAPA-HF trial (NEJM 2019)
Question 2 · Pharmaceutics, Biopharmaceutics & Pharmacokinetics
Many recombinant protein products, such as filgrastim and monoclonal antibodies, must be stored refrigerated and protected from agitation. What is the main stability concern this handling addresses?
- APhotolysis of aromatic side chains
- BOxidation of the polymeric coating
- CPhysical instability such as denaturation and aggregation of the protein
- DRacemization of the sugar backbone
Show answer and explanation
Correct answer: C. Physical instability such as denaturation and aggregation of the protein
Therapeutic proteins are prone to physical instability including unfolding (denaturation) and aggregation, which are accelerated by heat and mechanical stress such as shaking, and aggregates can reduce potency and increase immunogenicity. Refrigeration and gentle handling limit these processes; photolysis, coating oxidation, and sugar racemization are not the primary aggregation-related concerns for these products.
Reference: Crommelin, Pharmaceutical Biotechnology: Fundamentals and Applications, 5th ed., 2019
Question 3 · Basic Biomedical Sciences
In a purine base found in DNA, which structural feature distinguishes purines from pyrimidines?
- AA single six-membered nitrogen-containing ring
- BA fused double-ring system (a pyrimidine ring fused to an imidazole ring)
- CA ribose sugar instead of deoxyribose
- DThe presence of a methyl group at position 5
Show answer and explanation
Correct answer: B. A fused double-ring system (a pyrimidine ring fused to an imidazole ring)
Purines (adenine and guanine) have a bicyclic structure consisting of a six-membered pyrimidine ring fused to a five-membered imidazole ring. Pyrimidines (cytosine, thymine, uracil) have only a single six-membered ring. The sugar type distinguishes DNA from RNA, not purines from pyrimidines, and a 5-methyl group specifically characterizes thymine.
Reference: Lehninger Principles of Biochemistry, 8th ed., 2021
Question 4 · Pharmacy Law, Ethics & Regulatory Affairs
A pharmacist-investigator plans a trial enrolling adults who lack decision-making capacity. Which safeguard is most consistent with research ethics standards?
- AProceed without consent because the participants cannot object
- BObtain consent from a legally authorized representative, ensure the research cannot be done in a capable population, and obtain ethics committee approval
- CEnroll them only if the sponsor pays a higher fee
- DRely on verbal agreement from other patients in the ward
Show answer and explanation
Correct answer: B. Obtain consent from a legally authorized representative, ensure the research cannot be done in a capable population, and obtain ethics committee approval
Research with participants lacking capacity requires consent from a legally authorized representative, justification that the research cannot instead be conducted in a capable population, additional protections, and independent ethics committee approval. Proceeding without consent, basing enrollment on sponsor fees, or relying on unrelated patients' agreement all violate the protections owed to vulnerable participants.
Reference: World Medical Association Declaration of Helsinki (2013); ICH Good Clinical Practice E6(R2) (2016)
Question 5 · Toxicology & Poisoning Management
A patient receiving high cumulative doses of doxorubicin for chemotherapy is at greatest risk of which dose-dependent organ toxicity, and which agent is used to reduce it?
- ANephrotoxicity; prevented by mesna
- BDilated cardiomyopathy/heart failure; risk reduced by dexrazoxane
- CHepatotoxicity; prevented by N-acetylcysteine
- DOtotoxicity; prevented by amifostine
Show answer and explanation
Correct answer: B. Dilated cardiomyopathy/heart failure; risk reduced by dexrazoxane
Anthracyclines such as doxorubicin cause dose-dependent, potentially irreversible cardiotoxicity (dilated cardiomyopathy and heart failure), and dexrazoxane is an iron-chelating cardioprotectant used to reduce this risk. Mesna prevents ifosfamide/cyclophosphamide hemorrhagic cystitis, not anthracycline cardiotoxicity.
Reference: ESMO/ASCO cardio-oncology guidance; DiPiro Pharmacotherapy, 11th ed.
Question 6 · Public Health, Pharmacoeconomics, Pharmacoepidemiology & Biostatistics
In a trial, the event rate is 20% with placebo and 15% with a new drug. What is the number needed to treat (NNT) to prevent one event?
- A5
- B20
- C10
- D25
Show answer and explanation
Correct answer: B. 20
The absolute risk reduction is 20% minus 15%, which equals 5% or 0.05. The NNT is the reciprocal of the absolute risk reduction, so 1 divided by 0.05 equals 20. Values such as 5, 10, or 25 result from incorrect arithmetic or from confusing NNT with relative risk reduction.
Reference: Guyatt et al., Users' Guides to the Medical Literature (current)
Question 7 · Clinical Therapeutics & Disease-State Management
A 40-year-old man with bipolar disorder maintained on lithium develops vomiting, coarse tremor, confusion, and ataxia. He recently started a new medication for hypertension. Which co-prescribed drug most likely precipitated lithium toxicity by reducing its renal clearance?
- AAmlodipine
- BHydrochlorothiazide
- CDoxazosin
- DHydralazine
Show answer and explanation
Correct answer: B. Hydrochlorothiazide
Thiazide diuretics such as hydrochlorothiazide reduce renal lithium clearance by increasing proximal tubular reabsorption of sodium and lithium, leading to elevated lithium levels and toxicity manifest as tremor, ataxia, and confusion. Amlodipine, doxazosin, and hydralazine do not significantly impair lithium clearance.
Reference: Lithium prescribing information; standard pharmacotherapy and drug-interaction references
Question 8 · Pharmaceutical Calculations & Compounding
A 1 g antibiotic vial must yield a final volume of 4 mL after reconstitution. If the powder displacement volume is 0.7 mL, what volume of diluent should be added?
- A0.7 mL
- B3.3 mL
- C4 mL
- D4.7 mL
Show answer and explanation
Correct answer: B. 3.3 mL
Diluent volume = final volume − displacement volume = 4 mL − 0.7 mL = 3.3 mL. Adding the full 4 mL would ignore the powder's own volume and overfill the vial.
Reference: Ansel's Pharmaceutical Calculations, 15th ed. (2017)
Question 9 · Medicinal Chemistry, Pharmacognosy & Dietary Supplements
A neonate is at higher risk of chloramphenicol-induced gray baby syndrome. The underlying metabolic explanation is an immature capacity for which Phase II reaction?
- ASulfation
- BAcetylation
- CGlucuronidation
- DGlutathione conjugation
Show answer and explanation
Correct answer: C. Glucuronidation
Neonates have immature UDP-glucuronosyltransferase activity, so glucuronidation is deficient; chloramphenicol, which is normally inactivated by glucuronide conjugation, accumulates to toxic levels causing gray baby syndrome (cardiovascular collapse). Sulfation is relatively well developed at birth and partly compensates for other drugs, while acetylation and glutathione conjugation are not the rate-limiting deficient pathway responsible for this specific toxicity.
Reference: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 13th ed. (2018)
Question 10 · Nonprescription (OTC) & Self-Care / Counter Medication
An OTC weight-management product contains orlistat 60 mg. Which counseling point is essential for a patient starting it?
- AIt suppresses appetite centrally, so take it on an empty stomach
- BIt blocks dietary fat absorption and can cause oily/loose stools; take a multivitamin at bedtime
- CIt is safe to take with a very high-fat diet without GI effects
- DIt should be combined with a stimulant laxative for best results
Show answer and explanation
Correct answer: B. It blocks dietary fat absorption and can cause oily/loose stools; take a multivitamin at bedtime
Orlistat inhibits pancreatic lipase, blocking absorption of about a quarter of dietary fat, which can cause steatorrhea, oily spotting, and fecal urgency, and it reduces absorption of fat-soluble vitamins, so a multivitamin taken at bedtime (separated from doses) is advised. It is not a central appetite suppressant, GI effects worsen with high-fat meals, and adding a stimulant laxative is inappropriate.
Reference: Orlistat 60 mg OTC labeling; NICE weight management guidance
Free mock vs the full Pharmacist bank
The mock tells you where you stand. The bank is how you close the gap.
| What you get | Free mock | Full bank |
|---|---|---|
| Questions | 25 | 405+ |
| Papers | 1 short timed set | 3 to 6 full-length papers, about 135 each |
| Blueprint coverage | 13 of 13 domains | All 13 domains, 183 sub-topics |
| Worked rationale | Every question | Every question |
| Reference | Every question | Every question |
| Timing | 30 minutes in your browser | Exam-length papers to sit against the clock |
| Format | Online, free | PDF sent to you, yours to keep |
| Price | Free | AED 269, paid once |
Full Pharmacist bank
Close your gaps before exam day
- 405+ original questions in 3 to 6 full-length papers
- A worked rationale and a reference on every question
- Prepared for your regulator's blueprint and pass mark
One-time price
AED 269
About a third of one exam fee (about AED 880 per attempt)
Unlock the full bank →No subscription · yours to keep
Frequently asked questions
Is this Pharmacist mock test really free?
Are these real Pharmacist exam questions?
What is the pass mark for the Pharmacist exam?
How long is the Pharmacist exam and how many questions?
What topics does the Pharmacist exam cover?
How is the full Pharmacist bank different from this mock?
What score should I aim for on this Pharmacist mock?
Does passing this mock mean I will pass the real exam?
Which regulators is this Pharmacist mock for?
How many attempts do I get at the real exam?
Other free mock exams
Keep going
From a 25-question mock to the full Pharmacist bank
405+ original questions in 3 to 6 full-length papers, each with a worked rationale and a reference, written to the same blueprint as the free mock on this page. One price: AED 269.